My research interests have always been centered on glioblastoma (GBM) tumors, a particularly devastating brain tumor. My current research interests are centered around discovering new therapies for patients with GBM, which include pharmacological inhibition of the JAK/STAT pathway in patient-derived xenograft models, exploiting inflammatory (anti-tumor) macrophages to enhance standard of care in immunocompetent models, and understanding how the gut microbiome is altered by the diet as well as by certain drug therapies in mouse models of glioma.
